State Of Wyoming Invitae Corp Transaction History

State Of Wyoming

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.01 - $0.61 $32,362 - $1.97 Million	3,236,245 Added 781.24%	3,650,491 $36,000
Q4 2023 Feb 14, 2024	BUY	$0.42 - $0.72 $114,332 - $195,998	272,220 Added 191.67%	414,246 $260,000
Q3 2023 Nov 14, 2023	BUY	$0.6 - $1.53 $43,509 - $110,949	72,516 Added 104.32%	142,026 $85,000
Q2 2023 Aug 14, 2023	BUY	$1.05 - $1.63 $28,661 - $44,494	27,297 Added 64.66%	69,510 $78,000
Q1 2023 May 12, 2023	BUY	$1.2 - $2.73 $11,997 - $27,294	9,998 Added 31.04%	42,213 $56,000
Q4 2022 Feb 14, 2023	BUY	$1.71 - $3.61 $55,087 - $116,296	32,215 New	32,215 $59,000
Q2 2022 Aug 15, 2022	BUY	$2.13 - $9.01 $14,130 - $59,772	6,634 Added 314.56%	8,743 $21,000
Q1 2022 May 13, 2022	BUY	$6.28 - $15.59 $1,821 - $4,521	290 Added 15.94%	2,109 $17,000
Q4 2021 Feb 11, 2022	BUY	$14.7 - $28.67 $4,865 - $9,489	331 Added 22.24%	1,819 $28,000
Q3 2021 Feb 11, 2022	SELL	$24.31 - $33.6 $32,040 - $44,284	-1,318 Reduced 46.97%	1,488 $42,000
Q2 2021 Feb 11, 2022	BUY	$26.09 - $40.4 $40,465 - $62,660	1,551 Added 123.59%	2,806 $95,000
Q1 2021 Feb 08, 2022	BUY	$33.06 - $56.93 $41,490 - $71,447	1,255 New	1,255 $48,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.